Guangzhou Baiyunshan Pharmaceutical Holdings Company Limited Class H (GZPHF)
OTHER OTC:GZPHF
Holding GZPHF?
Track your performance easily

Guangzhou Baiyunshan Pharmaceutical Holdings Company (GZPHF) Income Statement

3 Followers

Guangzhou Baiyunshan Pharmaceutical Holdings Company Income Statement

Last quarter (Q ), Guangzhou Baiyunshan Pharmaceutical Holdings Company's total revenue was ¥15.98B, an increase of 3.28% from the same quarter last year. In Q, Guangzhou Baiyunshan Pharmaceutical Holdings Company's net income was ¥492.16M. See Guangzhou Baiyunshan Pharmaceutical Holdings Company’s key income statements, including revenue, expenses, profit, and income.
Income Statement
TTM
Dec 22Dec 21Dec 20Dec 19Dec 18
Total Revenue
¥ 70.79B¥ 70.79B¥ 69.01B¥ 61.67B¥ 64.95B¥ 42.23B
Cost of Revenue
¥ 57.51B¥ 57.51B¥ 55.78B¥ 51.23B¥ 52.73B¥ 32.16B
Gross Profit
¥ 13.28B¥ 13.28B¥ 13.23B¥ 10.44B¥ 12.22B¥ 10.07B
Operating Expense
¥ 8.73B¥ 8.73B¥ 8.85B¥ 6.96B¥ 8.16B¥ 7.41B
Operating Income
¥ 4.55B¥ 4.55B¥ 4.38B¥ 3.48B¥ 3.97B¥ 2.66B
Net Non Operating Interest Income Expense
¥ 173.57M¥ 173.57M¥ 124.34M¥ -7.25M¥ -113.80M¥ 11.75M
Other Income Expense
------
Pretax Income
¥ 5.04B¥ 5.04B¥ 4.72B¥ 3.74B¥ 4.13B¥ 4.02B
Tax Provision
¥ 789.87M¥ 789.87M¥ 754.09M¥ 647.45M¥ 687.25M¥ 485.01M
Earnings From Equity Interest Net Of Tax
------
Net Income Common Stockholders
¥ 3.97B¥ 3.97B¥ 3.72B¥ 2.92B¥ 3.19B¥ 3.44B
Basic EPS
¥ 2.44¥ 2.44¥ 2.29¥ 1.79¥ 1.96¥ 2.12
Diluted EPS
¥ 2.44¥ 2.44¥ 2.29¥ 1.79¥ 1.96¥ 2.12
Basic Average Shares
¥ 6.50B¥ 1.63B¥ 1.63B¥ 1.63B¥ 1.63B¥ 1.63B
Diluted Average Shares
¥ 6.50B¥ 1.63B¥ 1.63B¥ 1.63B¥ 1.63B¥ 1.63B
Dividend Per Share
¥ 0.69¥ 0.69¥ 0.55¥ 0.58¥ 0.42¥ 0.40
Total Operating Income As Reported
------
Reported Normalized Basic E P S
-¥ 2.04¥ 2.03¥ 1.62¥ 1.69¥ 1.31
Reported Normalized Diluted E P S
-¥ 2.04¥ 2.03¥ 1.62¥ 1.69¥ 1.31
Rent Expense Supplemental
-¥ 7.63M¥ 7.73M¥ 4.24M¥ 11.28M¥ 49.01M
Total Expenses
¥ 66.24B¥ 66.24B¥ 64.63B¥ 58.20B¥ 60.89B¥ 39.57B
Net Income From Continuing And Discontinued Operation
¥ 3.97B¥ 3.97B¥ 3.72B¥ 2.92B¥ 3.19B¥ 3.44B
Normalized Income
¥ 3.99B¥ 4.01B¥ 3.82B¥ 2.91B¥ 3.09B¥ 3.63B
Interest Expense
¥ 434.41M¥ 434.41M¥ 417.83M¥ 363.34M¥ 393.65M¥ 231.58M
EBIT
¥ 5.48B¥ 5.48B¥ 5.14B¥ 4.10B¥ 4.52B¥ 4.25B
EBITDA
¥ 5.48B¥ 6.22B¥ 5.46B¥ 4.42B¥ 5.11B¥ 4.55B
Currency in CNY

Guangzhou Baiyunshan Pharmaceutical Holdings Company Earnings and Revenue History

What am I Missing?
Make informed decisions based on Top Analysts' activity
Know what industry insiders are buying
Get actionable alerts from top Wall Street Analysts
Find out before anyone else which stock is going to shoot up
Get powerful stock screeners & detailed portfolio analysis